Enhancement and selective production of phoslactomycin B, a protein phosphatase IIa inhibitor, through identification and engineering of the corresponding biosynthetic gene cluster

Nadaraj Palaniappan, Beom Seok Kim, Yasuyo Sekiyama, Hiroyuki Osada, Kevin A. Reynolds

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Phoslactomycins (PLMs), potent and selective inhibitors of serine threonine phosphatases, are of interest for their antitumor and antiviral activity. Multiple analogs and low titers in the fermentation process have hampered the development of this class of natural products. The entire 75-kb PLM biosynthetic gene cluster of Streptomyces sp. HK-803 was cloned, sequenced, and analyzed. The loading domain and seven extension modules of the PLM polyketide synthase generate an unusual linear unsaturated polyketide chain containing both E- and Z-double bonds from a cyclohexanecarboxylic acid (CHC) primer. Hydroxylation of the CHC-derived side chain of the resulting PLM-B by PlmS 2, and a subsequent esterification, produces the remaining PLM analogs. A new PCR targeting technology allowed rapid and facile allelic replacement of plmS 2. The resulting mutant selectively produced the PLM-B, at 6-fold higher titers than the wild type strain. This mutant and the biosynthetic gene cluster will facilitate engineered microbial production of hybrid PLMs with improved properties.

Original languageEnglish
Pages (from-to)35552-35557
Number of pages6
JournalJournal of Biological Chemistry
Volume278
Issue number37
DOIs
Publication statusPublished - 2003 Sep 12
Externally publishedYes

Fingerprint

Phosphoprotein Phosphatases
Multigene Family
Genes
Polyketide Synthases
Polyketides
Hydroxylation
Esterification
Streptomyces
Biological Products
Fermentation
Antiviral Agents
Technology
Polymerase Chain Reaction
phoslactomycin B
cyclohexanecarboxylic acid

ASJC Scopus subject areas

  • Biochemistry

Cite this

Enhancement and selective production of phoslactomycin B, a protein phosphatase IIa inhibitor, through identification and engineering of the corresponding biosynthetic gene cluster. / Palaniappan, Nadaraj; Kim, Beom Seok; Sekiyama, Yasuyo; Osada, Hiroyuki; Reynolds, Kevin A.

In: Journal of Biological Chemistry, Vol. 278, No. 37, 12.09.2003, p. 35552-35557.

Research output: Contribution to journalArticle

@article{30cadc973c7a4b7fae8e0a1330ad48ae,
title = "Enhancement and selective production of phoslactomycin B, a protein phosphatase IIa inhibitor, through identification and engineering of the corresponding biosynthetic gene cluster",
abstract = "Phoslactomycins (PLMs), potent and selective inhibitors of serine threonine phosphatases, are of interest for their antitumor and antiviral activity. Multiple analogs and low titers in the fermentation process have hampered the development of this class of natural products. The entire 75-kb PLM biosynthetic gene cluster of Streptomyces sp. HK-803 was cloned, sequenced, and analyzed. The loading domain and seven extension modules of the PLM polyketide synthase generate an unusual linear unsaturated polyketide chain containing both E- and Z-double bonds from a cyclohexanecarboxylic acid (CHC) primer. Hydroxylation of the CHC-derived side chain of the resulting PLM-B by PlmS 2, and a subsequent esterification, produces the remaining PLM analogs. A new PCR targeting technology allowed rapid and facile allelic replacement of plmS 2. The resulting mutant selectively produced the PLM-B, at 6-fold higher titers than the wild type strain. This mutant and the biosynthetic gene cluster will facilitate engineered microbial production of hybrid PLMs with improved properties.",
author = "Nadaraj Palaniappan and Kim, {Beom Seok} and Yasuyo Sekiyama and Hiroyuki Osada and Reynolds, {Kevin A.}",
year = "2003",
month = "9",
day = "12",
doi = "10.1074/jbc.M305082200",
language = "English",
volume = "278",
pages = "35552--35557",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "37",

}

TY - JOUR

T1 - Enhancement and selective production of phoslactomycin B, a protein phosphatase IIa inhibitor, through identification and engineering of the corresponding biosynthetic gene cluster

AU - Palaniappan, Nadaraj

AU - Kim, Beom Seok

AU - Sekiyama, Yasuyo

AU - Osada, Hiroyuki

AU - Reynolds, Kevin A.

PY - 2003/9/12

Y1 - 2003/9/12

N2 - Phoslactomycins (PLMs), potent and selective inhibitors of serine threonine phosphatases, are of interest for their antitumor and antiviral activity. Multiple analogs and low titers in the fermentation process have hampered the development of this class of natural products. The entire 75-kb PLM biosynthetic gene cluster of Streptomyces sp. HK-803 was cloned, sequenced, and analyzed. The loading domain and seven extension modules of the PLM polyketide synthase generate an unusual linear unsaturated polyketide chain containing both E- and Z-double bonds from a cyclohexanecarboxylic acid (CHC) primer. Hydroxylation of the CHC-derived side chain of the resulting PLM-B by PlmS 2, and a subsequent esterification, produces the remaining PLM analogs. A new PCR targeting technology allowed rapid and facile allelic replacement of plmS 2. The resulting mutant selectively produced the PLM-B, at 6-fold higher titers than the wild type strain. This mutant and the biosynthetic gene cluster will facilitate engineered microbial production of hybrid PLMs with improved properties.

AB - Phoslactomycins (PLMs), potent and selective inhibitors of serine threonine phosphatases, are of interest for their antitumor and antiviral activity. Multiple analogs and low titers in the fermentation process have hampered the development of this class of natural products. The entire 75-kb PLM biosynthetic gene cluster of Streptomyces sp. HK-803 was cloned, sequenced, and analyzed. The loading domain and seven extension modules of the PLM polyketide synthase generate an unusual linear unsaturated polyketide chain containing both E- and Z-double bonds from a cyclohexanecarboxylic acid (CHC) primer. Hydroxylation of the CHC-derived side chain of the resulting PLM-B by PlmS 2, and a subsequent esterification, produces the remaining PLM analogs. A new PCR targeting technology allowed rapid and facile allelic replacement of plmS 2. The resulting mutant selectively produced the PLM-B, at 6-fold higher titers than the wild type strain. This mutant and the biosynthetic gene cluster will facilitate engineered microbial production of hybrid PLMs with improved properties.

UR - http://www.scopus.com/inward/record.url?scp=0041816073&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0041816073&partnerID=8YFLogxK

U2 - 10.1074/jbc.M305082200

DO - 10.1074/jbc.M305082200

M3 - Article

C2 - 12819191

AN - SCOPUS:0041816073

VL - 278

SP - 35552

EP - 35557

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 37

ER -